These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 18075190

  • 1. Monitoring, removal and risk assessment of cytostatic drugs in hospital wastewater.
    Lenz K, Mahnik SN, Weissenbacher N, Mader RM, Krenn P, Hann S, Koellensperger G, Uhl M, Knasmüller S, Ferk F, Bursch W, Fuerhacker M.
    Water Sci Technol; 2007; 56(12):141-9. PubMed ID: 18075190
    [Abstract] [Full Text] [Related]

  • 2. Fate of 5-fluorouracil, doxorubicin, epirubicin, and daunorubicin in hospital wastewater and their elimination by activated sludge and treatment in a membrane-bio-reactor system.
    Mahnik SN, Lenz K, Weissenbacher N, Mader RM, Fuerhacker M.
    Chemosphere; 2007 Jan; 66(1):30-7. PubMed ID: 16839587
    [Abstract] [Full Text] [Related]

  • 3. Fate of cancerostatic platinum compounds in biological wastewater treatment of hospital effluents.
    Lenz K, Koellensperger G, Hann S, Weissenbacher N, Mahnik SN, Fuerhacker M.
    Chemosphere; 2007 Nov; 69(11):1765-74. PubMed ID: 17624406
    [Abstract] [Full Text] [Related]

  • 4. Presence of cancerostatic platinum compounds in hospital wastewater and possible elimination by adsorption to activated sludge.
    Lenz K, Hann S, Koellensperger G, Stefanka Z, Stingeder G, Weissenbacher N, Mahnik SN, Fuerhacker M.
    Sci Total Environ; 2005 Jun 01; 345(1-3):141-52. PubMed ID: 15919535
    [Abstract] [Full Text] [Related]

  • 5. A preliminary study on the occurrence of cytostatic drugs in hospital effluents in Beijing, China.
    Yin J, Shao B, Zhang J, Li K.
    Bull Environ Contam Toxicol; 2010 Jan 01; 84(1):39-45. PubMed ID: 19795089
    [Abstract] [Full Text] [Related]

  • 6. [Research advance of toxicological risk of hospital wastewater to aquatic environment].
    Sun YX, Zhang GH, Gu P.
    Wei Sheng Yan Jiu; 2006 Mar 01; 35(2):244-6. PubMed ID: 16758982
    [Abstract] [Full Text] [Related]

  • 7. Treatment of hospital wastewater effluent by nanofiltration and reverse osmosis.
    Beier S, Köster S, Veltmann K, Schröder H, Pinnekamp J.
    Water Sci Technol; 2010 Mar 01; 61(7):1691-8. PubMed ID: 20371926
    [Abstract] [Full Text] [Related]

  • 8. MBR technology: a promising approach for the (pre-)treatment of hospital wastewater.
    Beier S, Cramer C, Mauer C, Köster S, Schröder HF, Pinnekamp J.
    Water Sci Technol; 2012 Mar 01; 65(9):1648-53. PubMed ID: 22508128
    [Abstract] [Full Text] [Related]

  • 9. Fate and removal of estrogens in municipal wastewater.
    Racz L, Goel RK.
    J Environ Monit; 2010 Jan 01; 12(1):58-70. PubMed ID: 20082000
    [Abstract] [Full Text] [Related]

  • 10. Preliminary study of physico-chemical treatment options for hospital wastewater.
    Gautam AK, Kumar S, Sabumon PC.
    J Environ Manage; 2007 May 01; 83(3):298-306. PubMed ID: 16824671
    [Abstract] [Full Text] [Related]

  • 11. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment.
    Radjenović J, Petrović M, Barceló D.
    Water Res; 2009 Feb 01; 43(3):831-41. PubMed ID: 19091371
    [Abstract] [Full Text] [Related]

  • 12. A novel application of TPAD-MBR system to the pilot treatment of chemical synthesis-based pharmaceutical wastewater.
    Chen Z, Ren N, Wang A, Zhang ZP, Shi Y.
    Water Res; 2008 Jul 01; 42(13):3385-92. PubMed ID: 18538367
    [Abstract] [Full Text] [Related]

  • 13. Environmental toxicology and risk assessment of pharmaceuticals from hospital wastewater.
    Escher BI, Baumgartner R, Koller M, Treyer K, Lienert J, McArdell CS.
    Water Res; 2011 Jan 01; 45(1):75-92. PubMed ID: 20828784
    [Abstract] [Full Text] [Related]

  • 14. Removal of ibuprofen from wastewater: comparing biodegradation in conventional, membrane bioreactor, and biological nutrient removal treatment systems.
    Smook TM, Zho H, Zytner RG.
    Water Sci Technol; 2008 Jan 01; 57(1):1-8. PubMed ID: 18192734
    [Abstract] [Full Text] [Related]

  • 15. Fate of glutaraldehyde in hospital wastewater and combined effects of glutaraldehyde and surfactants on aquatic organisms.
    Emmanuel E, Hanna K, Bazin C, Keck G, Clément B, Perrodin Y.
    Environ Int; 2005 Apr 01; 31(3):399-406. PubMed ID: 15734192
    [Abstract] [Full Text] [Related]

  • 16. Investigation on the behaviour of selected pharmaceuticals in the groundwater after infiltration of treated wastewater.
    Kreuzinger N, Clara M, Strenn B, Vogel B.
    Water Sci Technol; 2004 Apr 01; 50(2):221-8. PubMed ID: 15344795
    [Abstract] [Full Text] [Related]

  • 17. Simplified protocol for evaluating the genotoxic risk of hospital wastewater.
    Jolibois B, Guerbet M.
    Environ Toxicol; 2006 Apr 01; 21(2):141-6. PubMed ID: 16528689
    [Abstract] [Full Text] [Related]

  • 18. Full scale membrane bioreactor treatment of hospital wastewater as forerunner for hot-spot wastewater treatment solutions in high density urban areas.
    Beier S, Cramer C, Köster S, Mauer C, Palmowski L, Schröder HF, Pinnekamp J.
    Water Sci Technol; 2011 Apr 01; 63(1):66-71. PubMed ID: 21245555
    [Abstract] [Full Text] [Related]

  • 19. Fate of pharmaceuticals and personal care products in wastewater treatment plants--conception of a database and first results.
    Miège C, Choubert JM, Ribeiro L, Eusèbe M, Coquery M.
    Environ Pollut; 2009 May 01; 157(5):1721-6. PubMed ID: 19201071
    [Abstract] [Full Text] [Related]

  • 20. In vitro characterization of the effectiveness of enhanced sewage treatment processes to eliminate endocrine activity of hospital effluents.
    Maletz S, Floehr T, Beier S, Klümper C, Brouwer A, Behnisch P, Higley E, Giesy JP, Hecker M, Gebhardt W, Linnemann V, Pinnekamp J, Hollert H.
    Water Res; 2013 Mar 15; 47(4):1545-57. PubMed ID: 23305681
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.